WuXi Biologics Announces US$400 Million On-Market Share Repurchase Plan Under Shareholder Mandate 12
WuXi Biologics Announces Major Share Repurchase Program Wu...
Sign in to continue:
WuXi Biologics Announces Major Share Repurchase Program Wu...
Excerpt from OCBC Group report. Report Summary Stock: Si...
GoFintech Quantum Innovation Limited Announces Strategic Inv...
Broker: Lim & Tan Securities Date of Report: 26 May 2026 Exc...
CF PharmTech Announces Acceptance of Tiotropium Bromide Inha...
Broker Name: Lim & Tan Securities Date of Report: 25 May 202...
SSY Group Limited Announces Regulatory Approval for Safinami...
Broker Name: CGS International Date of Report: May 26, 2026 ...
Wasion Holdings Secures Over RMB1.6 Billion in New Overseas ...
Broker: Maybank Research Pte Ltd Date of Report: 25 May 2026...